抗病毒治疗在HBV相关性肝癌中的应用现状与展望

乙型肝炎病毒是我国原发性肝癌的主要病因,肝癌的进展、治疗效果、复发和生存率与是否给予抗病毒治疗密切相关。欲提高其疗效,抗病毒治疗是关键,只要存在适应证就必须进行。抗病毒治疗迄今仍被认为是治疗肝癌的最基本病因治疗,能明显抑制乙肝病毒复制,减轻肝脏损害,提高肝癌治疗的疗效。

Application and Prospects of Antiviral Therapy in HBV Related Hepatoma

Hepatitis B virus（HBV） is the main cause of primary hepatic cancer in China. The progression, of hepatoma, the therapeutic effeet, the recurrence, and the survival rate are closely related to the application of antiviral therapy. To enhance the efficacy of hepatoma, antiviral treatment is essential and must be taken unless it is not fit for this kind of treatment. Antiviral therapy is still considered to be the most fundamental treatment to hepatoma so far, which can significantly inhibit HBV replication, reduce the liver damage, and increase the treatment efficiency considerably on oatients with heoatoma.